Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
4.800
+0.085 (1.80%)
Aug 25, 2025, 10:25 AM - Market open

Acurx Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
814534644-
Upgrade
Market Cap Growth
-66.35%-73.92%14.29%4.51%--
Upgrade
Enterprise Value
18463630-
Upgrade
Last Close Price
4.7116.2876.6079.6086.43-
Upgrade
PB Ratio
1.9422.3511.306.313.56-
Upgrade
P/TBV Ratio
2.1022.3511.306.313.56-
Upgrade
Debt / Equity Ratio
-----0.03
Upgrade
Quick Ratio
2.361.162.504.4215.366.72
Upgrade
Current Ratio
2.381.192.534.5515.716.82
Upgrade
Return on Equity (ROE)
-285.94%-534.03%-243.33%-122.61%-168.71%-261.26%
Upgrade
Return on Assets (ROA)
-98.58%-152.41%-106.65%-66.79%-97.21%-99.91%
Upgrade
Return on Capital (ROIC)
-179.56%-333.77%-152.08%-76.63%-105.53%-160.26%
Upgrade
Earnings Yield
-133.81%-102.56%-27.64%-26.21%-28.88%-
Upgrade
Buyback Yield / Dilution
-32.55%-27.56%-17.15%-26.72%-37.88%-30.29%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q